The antitumour agent 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (DTIC) inhibits rat liver cAMP phosphodiesterase and amplifies hormone effects in hepatocytes and hepatoma cells.

The antitumour agent 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC) was found to inhibit competitively the low-Km cyclic AMP phosphodiesterase activity in an ammonium-sulphate-precipitable fraction of the 2,000g supernatant of rat liver. With substrate concentration at 0.25 microM, I50 wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Larsson, P. G., Haffner, F., Brłnstad, G. O., Christoffersen, T.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1979
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010101/
https://www.ncbi.nlm.nih.gov/pubmed/228692
_version_ 1782136250406273024
author Larsson, P. G.
Haffner, F.
Brłnstad, G. O.
Christoffersen, T.
author_facet Larsson, P. G.
Haffner, F.
Brłnstad, G. O.
Christoffersen, T.
author_sort Larsson, P. G.
collection PubMed
description The antitumour agent 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC) was found to inhibit competitively the low-Km cyclic AMP phosphodiesterase activity in an ammonium-sulphate-precipitable fraction of the 2,000g supernatant of rat liver. With substrate concentration at 0.25 microM, I50 was 790 microM for DTIC and 350 microM for theophylline. DTIC at 2 mM more than doubled the cAMP response to glucagon in hepatocytes and to adrenaline in MH1C1 hepatoma cells, indicating that it also exerts its inhibitory effect on the phosphodiesterase in intact cells. The possible contribution of the phosphodiesterase inhibition to the growth-inhibitory and cytotoxic effects of DTIC is discussed.
format Text
id pubmed-2010101
institution National Center for Biotechnology Information
language English
publishDate 1979
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-20101012009-09-10 The antitumour agent 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (DTIC) inhibits rat liver cAMP phosphodiesterase and amplifies hormone effects in hepatocytes and hepatoma cells. Larsson, P. G. Haffner, F. Brłnstad, G. O. Christoffersen, T. Br J Cancer Research Article The antitumour agent 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (DTIC) was found to inhibit competitively the low-Km cyclic AMP phosphodiesterase activity in an ammonium-sulphate-precipitable fraction of the 2,000g supernatant of rat liver. With substrate concentration at 0.25 microM, I50 was 790 microM for DTIC and 350 microM for theophylline. DTIC at 2 mM more than doubled the cAMP response to glucagon in hepatocytes and to adrenaline in MH1C1 hepatoma cells, indicating that it also exerts its inhibitory effect on the phosphodiesterase in intact cells. The possible contribution of the phosphodiesterase inhibition to the growth-inhibitory and cytotoxic effects of DTIC is discussed. Nature Publishing Group 1979-11 /pmc/articles/PMC2010101/ /pubmed/228692 Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Research Article
Larsson, P. G.
Haffner, F.
Brłnstad, G. O.
Christoffersen, T.
The antitumour agent 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (DTIC) inhibits rat liver cAMP phosphodiesterase and amplifies hormone effects in hepatocytes and hepatoma cells.
title The antitumour agent 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (DTIC) inhibits rat liver cAMP phosphodiesterase and amplifies hormone effects in hepatocytes and hepatoma cells.
title_full The antitumour agent 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (DTIC) inhibits rat liver cAMP phosphodiesterase and amplifies hormone effects in hepatocytes and hepatoma cells.
title_fullStr The antitumour agent 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (DTIC) inhibits rat liver cAMP phosphodiesterase and amplifies hormone effects in hepatocytes and hepatoma cells.
title_full_unstemmed The antitumour agent 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (DTIC) inhibits rat liver cAMP phosphodiesterase and amplifies hormone effects in hepatocytes and hepatoma cells.
title_short The antitumour agent 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (DTIC) inhibits rat liver cAMP phosphodiesterase and amplifies hormone effects in hepatocytes and hepatoma cells.
title_sort antitumour agent 5-(3,3-dimethyl-1-triazeno) imidazole-4-carboxamide (dtic) inhibits rat liver camp phosphodiesterase and amplifies hormone effects in hepatocytes and hepatoma cells.
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2010101/
https://www.ncbi.nlm.nih.gov/pubmed/228692
work_keys_str_mv AT larssonpg theantitumouragent533dimethyl1triazenoimidazole4carboxamidedticinhibitsratlivercampphosphodiesteraseandamplifieshormoneeffectsinhepatocytesandhepatomacells
AT haffnerf theantitumouragent533dimethyl1triazenoimidazole4carboxamidedticinhibitsratlivercampphosphodiesteraseandamplifieshormoneeffectsinhepatocytesandhepatomacells
AT brłnstadgo theantitumouragent533dimethyl1triazenoimidazole4carboxamidedticinhibitsratlivercampphosphodiesteraseandamplifieshormoneeffectsinhepatocytesandhepatomacells
AT christoffersent theantitumouragent533dimethyl1triazenoimidazole4carboxamidedticinhibitsratlivercampphosphodiesteraseandamplifieshormoneeffectsinhepatocytesandhepatomacells
AT larssonpg antitumouragent533dimethyl1triazenoimidazole4carboxamidedticinhibitsratlivercampphosphodiesteraseandamplifieshormoneeffectsinhepatocytesandhepatomacells
AT haffnerf antitumouragent533dimethyl1triazenoimidazole4carboxamidedticinhibitsratlivercampphosphodiesteraseandamplifieshormoneeffectsinhepatocytesandhepatomacells
AT brłnstadgo antitumouragent533dimethyl1triazenoimidazole4carboxamidedticinhibitsratlivercampphosphodiesteraseandamplifieshormoneeffectsinhepatocytesandhepatomacells
AT christoffersent antitumouragent533dimethyl1triazenoimidazole4carboxamidedticinhibitsratlivercampphosphodiesteraseandamplifieshormoneeffectsinhepatocytesandhepatomacells

Ejemplares similares